Kennedy Capital Management, Inc. Bio Xcel Therapeutics, Inc. Transaction History

Kennedy Capital Management, Inc.

  • $4.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$23.84 - $32.03 $966,282 - $1.3 Million
-40,532 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$29.06 - $38.83 $24,439 - $32,656
-841 Reduced 2.03%
40,532 $1.18 Million
Q1 2021

May 14, 2021
BUY
$39.04 - $64.6 $1.62 Million - $2.67 Million
41,373 New
41,373 $1.79 Million

Others Institutions Holding BTAI

# of Institutions
55
Shares Held
3.14M
Call Options Held
22.2K
Put Options Held
40.2K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $12.9M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email